ESMA has launched a Call for Evidence on the market structure of European equity markets, opening a formal window for buy-side desks, sell-side firms, trading venues and vendors to submit data and views on how the region's equity market is organized and functioning.

The announcement, reported by Global Regulation Tomorrow, signals the start of an evidence-gathering phase rather than a rulemaking step. No binding requirements, compliance deadlines or effective dates attach to a Call for Evidence. What it does is put market participants on notice that the regulator is assembling the record on which any future consultation, technical advice or rule proposal would be built.

What does a Call for Evidence actually change?

Nothing is mandated at this stage. A Call for Evidence is a pre-consultation instrument: the regulator invites submissions describing current practices, volumes, costs and pain points before deciding whether formal policy work is warranted.

For execution and compliance teams, the practical workflow implication is document-gathering, not code changes:

• No new rules take effect and no compliance deadline exists.
• Submissions typically require internal data on routing, venue usage and execution outcomes.
• Responses become part of the public record that shapes any subsequent consultation paper.

Desks that have dealt with prior ESMA reviews will recognize the sequence: Call for Evidence first, then a consultation paper with draft technical standards or guidance, then final report and implementation dates. Each stage carries its own comment window.

Why should trading desks care now?

European equity market structure has been the subject of repeated regulatory review since MiFID II reshaped venue competition, transparency and best-execution obligations. Any fresh examination of that structure touches the core of execution workflow: where orders route, which venues and mechanisms compete for flow, how transaction and market data are priced, and what evidence firms must retain to demonstrate best execution.

The stakes for cost and technology choices are direct. If the evidence gathered here feeds into future proposals on data consolidation, venue tick-size regimes or the treatment of specific execution mechanisms, firms face build-or-buy decisions on monitoring, reporting and routing infrastructure.

Buy-side participants in particular have a standing interest in these reviews, since market-structure outcomes determine the quality and price of the data they rely on for execution analysis and TCA.

Mandated versus proposed — where this sits

To separate the categories clearly:

• Mandated: Nothing in this announcement. A Call for Evidence imposes no obligations on market participants.
• Proposed: Nothing yet. No draft rules, technical standards or guidance texts accompany this step.
• Invited: Submissions of evidence and views from stakeholders on the current structure of European equity markets.

That distinction matters for planning. Compliance calendars do not move on this news. Strategy calendars might, because firms that respond early to evidence requests tend to shape the framing of whatever consultation follows.

What comes next

The next observable milestones in this process would be the close of the response period for submissions and any subsequent ESMA publication — either a consultation paper with concrete draft measures or a report concluding no action is warranted. Until one of those documents appears, desks should treat this as intelligence-gathering on the regulator's part, and decide whether their own execution, data and venue data is organized well enough to submit on short notice.